The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and children with diabetes, the agency announced Friday. Like its reference ...
Merilog administered subcutaneously 5 to 10 minutes before mealtime helps improve glycemic control. (HealthDay News) — The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback